Global Needle-Free Drug Delivery Market, By Product (Prefilled Needle-Free Injection Systems and Fillable Needle-Free Injection Systems), Technology (Inhaler, Novel Needle-Free, Jet Injector and Transdermal Patch), Application (Insulin Delivery, Vaccination, Pediatric Injections and Pain Management), Injection Method (Powder injections, Liquid injections and Depot or Projectile Injection), Source of Power (Spring Load Jet Injector Systems, Gas Powdered Jet Injector and Battery Powdered Jet Injector System), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Needle-free drug delivery market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 21.04 billion by 2028 growing at a CAGR of 9.95% in the above-mentioned forecast period. The increasing prevalence of diabetes and chronic diseases, and demand for pain-free delivery of drugs has been directly impacting the growth of needle-free drug delivery market.
Needle-free drug delivery systems are an innovative way and method of delivery of drugs and other types of medicines. They can also be forms of transdermal patches, inhaling systems or even micro-needles that do not pierce the skin like a conventional needle.
High amount of prevalence of diabetes worldwide is the main factor which is driving the needle-free drug delivery market. Reduction in risk of transferring of infection and pain associated with normal needle delivery methods is the main opportunity for the growth of needle-free drug delivery market.
Limitations and drawbacks associated with the devices such as blockage and restrictions of flow of drugs is due to the tissue getting stuck in the needle openings is the main challenge for the needle-free drug delivery market. However, high cost of these devices is the main restraint in the growth of needle-free drug delivery market during the forecast period of 2021-2028.
This needle-free drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research needle-free drug delivery market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
In May 2018, Namaste Technologies Inc. partnered with Inolife Sciences to commercialize and apply Inolife’s needle-free technology to deliver medical cannabis. The company aims for producing medical cannabis oil via this partnership.
Needle-Free Drug Delivery Market Scope and Market Size
Needle-free drug delivery market is segmented on the basis of product, technology, application, injection method and source of power. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on product, the needle-free drug delivery market is segmented into prefilled needle-free injection systems and fillable needle-free injection systems.
- Based on technology, the needle-free drug delivery market is segmented into inhaler, novel needle-free, jet injector and transdermal patch.
- On basis of application, the needle-free drug delivery market is segmented into insulin delivery, vaccination, pediatric injections and pain management.
- Based on injection method, the needle-free drug delivery market is segmented into powder injections, liquid injections and depot or projectile injection.
- Based on source of power, the needle-free drug delivery market is segmented into spring load jet injector systems, gas powdered jet injector and battery powdered jet injector system.
Needle-Free Drug Delivery Market Country Level Analysis
Needle-free drug delivery market is analysed and market size insights and trends are provided by country, product, technology, application, injection method and source of power as referenced above.
The countries covered in the needle-free drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is likely to lead the needle-free drug delivery market. High awareness regarding potential benefits of needle-free drug delivery devices and presence of well-developed healthcare facilities and extensive R&D expenditure by government organizations and pharmaceutical companies for diabetes and chronic pain management is the key factor for the growth of needle-free drug delivery market in this region. The market in Asia-Pacific is expected to exhibit a substantial growth rate during the forecast period 2021-2028 due to rising prevalence of diabetes in developing countries such as India and China.
The country section of the needle-free drug delivery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Needle-free drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for needle-free drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the needle-free drug delivery market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Needle-Free Drug Delivery Market Share Analysis
Needle-free drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to needle-free drug delivery market.
The major players covered in the needle-free drug delivery market report are Antares Pharmed, Inc., Tianjin Xuying Technology Development Co. Ltd., Verdict Media Limited, 3M, PharmaJet, Zogenix, Inovio Pharmaceuticals Inc., Valeritas Inc, Akra Dermo-Jet, D'Antonio Consultants International Inc., Endo Pharmaceuticals Inc., BD, CROSSJECT, MIT Canada, MedImmune, Mystic Pharmaceuticals, Needle Free Injection System, Inolife Sciences, Ferring B.V., OptiNose US Inc., and Pfizer Inc. are among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.